| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Point-of-Care Systems | 34 | 2022 | 1177 | 5.160 |
Why?
|
| Clinical Laboratory Techniques | 21 | 2019 | 738 | 3.610 |
Why?
|
| Laboratories, Hospital | 15 | 2017 | 194 | 3.010 |
Why?
|
| Academic Medical Centers | 19 | 2021 | 2759 | 2.470 |
Why?
|
| Pathology, Clinical | 8 | 2018 | 368 | 2.060 |
Why?
|
| Troponin T | 17 | 2022 | 754 | 1.790 |
Why?
|
| Laboratories | 7 | 2019 | 463 | 1.780 |
Why?
|
| Running | 12 | 2009 | 480 | 1.510 |
Why?
|
| Lyme Disease | 3 | 2023 | 621 | 1.300 |
Why?
|
| Natriuretic Peptide, Brain | 14 | 2017 | 1573 | 1.250 |
Why?
|
| Borrelia | 2 | 2023 | 67 | 1.150 |
Why?
|
| Pancreatic Cyst | 15 | 2010 | 368 | 1.130 |
Why?
|
| Clinical Laboratory Information Systems | 6 | 2015 | 108 | 1.060 |
Why?
|
| Troponin | 9 | 2023 | 524 | 1.030 |
Why?
|
| Blood Chemical Analysis | 7 | 2015 | 440 | 0.980 |
Why?
|
| Utilization Review | 4 | 2011 | 392 | 0.810 |
Why?
|
| Myocardial Infarction | 15 | 2023 | 11727 | 0.790 |
Why?
|
| Cystadenocarcinoma, Mucinous | 9 | 1998 | 49 | 0.780 |
Why?
|
| Clinical Chemistry Tests | 3 | 2008 | 61 | 0.760 |
Why?
|
| Immunochemistry | 2 | 2018 | 124 | 0.740 |
Why?
|
| Creatine Kinase | 13 | 2014 | 694 | 0.710 |
Why?
|
| Quality Control | 4 | 2018 | 841 | 0.700 |
Why?
|
| Chemistry, Clinical | 2 | 2018 | 64 | 0.700 |
Why?
|
| Peptide Fragments | 9 | 2017 | 5097 | 0.670 |
Why?
|
| Physical Endurance | 4 | 2007 | 370 | 0.670 |
Why?
|
| Hyponatremia | 4 | 2009 | 298 | 0.630 |
Why?
|
| Pancreatic Pseudocyst | 8 | 1998 | 110 | 0.630 |
Why?
|
| Myoglobin | 6 | 2005 | 160 | 0.620 |
Why?
|
| Occult Blood | 3 | 2010 | 176 | 0.580 |
Why?
|
| Length of Stay | 7 | 2016 | 6309 | 0.570 |
Why?
|
| Quality Assurance, Health Care | 10 | 2011 | 2212 | 0.560 |
Why?
|
| Electrolytes | 1 | 2017 | 282 | 0.560 |
Why?
|
| Intensive Care Units | 8 | 2017 | 3679 | 0.560 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2014 | 153 | 0.540 |
Why?
|
| Magnesium | 2 | 2017 | 813 | 0.530 |
Why?
|
| Urinalysis | 3 | 2010 | 369 | 0.510 |
Why?
|
| Pancreatic Neoplasms | 22 | 2004 | 5256 | 0.500 |
Why?
|
| Acidosis, Lactic | 2 | 2013 | 142 | 0.480 |
Why?
|
| Acute Coronary Syndrome | 3 | 2014 | 2337 | 0.480 |
Why?
|
| Hematocrit | 2 | 2015 | 636 | 0.470 |
Why?
|
| Pancreatitis | 21 | 2013 | 1092 | 0.450 |
Why?
|
| Influenza B virus | 1 | 2013 | 50 | 0.450 |
Why?
|
| Troponin I | 6 | 2005 | 619 | 0.440 |
Why?
|
| Myocardial Stunning | 2 | 2006 | 68 | 0.430 |
Why?
|
| Microbiological Techniques | 1 | 2013 | 102 | 0.430 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 3 | 2009 | 426 | 0.430 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2019 | 1164 | 0.430 |
Why?
|
| Chest Pain | 6 | 2019 | 1114 | 0.430 |
Why?
|
| Humans | 157 | 2023 | 744343 | 0.420 |
Why?
|
| Ambulatory Care | 3 | 2014 | 2708 | 0.400 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2011 | 30 | 0.400 |
Why?
|
| Hypernatremia | 2 | 2009 | 82 | 0.390 |
Why?
|
| Critical Care | 4 | 2017 | 2647 | 0.390 |
Why?
|
| Health Planning Guidelines | 3 | 2011 | 163 | 0.390 |
Why?
|
| Reference Values | 14 | 2014 | 4982 | 0.380 |
Why?
|
| Fish Oils | 2 | 2005 | 470 | 0.370 |
Why?
|
| Pathology | 1 | 2013 | 272 | 0.370 |
Why?
|
| Lactic Acid | 2 | 2013 | 1133 | 0.370 |
Why?
|
| Efficiency, Organizational | 5 | 2011 | 695 | 0.370 |
Why?
|
| Internal Medicine | 1 | 2017 | 1009 | 0.360 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 5 | 1994 | 139 | 0.360 |
Why?
|
| Emergency Medical Services | 4 | 2011 | 1917 | 0.360 |
Why?
|
| Influenza, Human | 2 | 2013 | 1479 | 0.360 |
Why?
|
| Blood Glucose | 8 | 2022 | 6256 | 0.350 |
Why?
|
| Creatinine | 2 | 2015 | 1919 | 0.350 |
Why?
|
| Influenza A virus | 1 | 2013 | 456 | 0.350 |
Why?
|
| Trypsinogen | 12 | 1999 | 86 | 0.340 |
Why?
|
| Hemoglobins | 2 | 2015 | 1534 | 0.340 |
Why?
|
| Cystadenoma, Serous | 5 | 1998 | 102 | 0.340 |
Why?
|
| Guaiac | 1 | 2008 | 12 | 0.340 |
Why?
|
| Cystadenoma | 4 | 1994 | 84 | 0.340 |
Why?
|
| Antigens, Neoplasm | 4 | 2004 | 1988 | 0.340 |
Why?
|
| Lipoproteins | 1 | 2014 | 878 | 0.330 |
Why?
|
| Inpatients | 2 | 2019 | 2518 | 0.320 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2017 | 783 | 0.320 |
Why?
|
| Shock | 2 | 2008 | 318 | 0.320 |
Why?
|
| Myocardium | 5 | 2014 | 4776 | 0.320 |
Why?
|
| Critical Illness | 3 | 2017 | 2670 | 0.310 |
Why?
|
| Creatine Kinase, MB Form | 8 | 2009 | 214 | 0.310 |
Why?
|
| Dyspnea | 5 | 2012 | 1303 | 0.300 |
Why?
|
| Creatine | 1 | 2009 | 421 | 0.300 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 2268 | 0.300 |
Why?
|
| Arginine Vasopressin | 1 | 2007 | 130 | 0.290 |
Why?
|
| Pancreas | 22 | 2013 | 1686 | 0.290 |
Why?
|
| Sensitivity and Specificity | 14 | 2023 | 14722 | 0.290 |
Why?
|
| Blood Donors | 2 | 2006 | 355 | 0.290 |
Why?
|
| Isoenzymes | 9 | 2005 | 1726 | 0.280 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2291 | 0.280 |
Why?
|
| Myocarditis | 1 | 2014 | 771 | 0.280 |
Why?
|
| Metformin | 1 | 2013 | 835 | 0.280 |
Why?
|
| Carcinoembryonic Antigen | 6 | 2004 | 349 | 0.270 |
Why?
|
| General Surgery | 1 | 2017 | 1636 | 0.270 |
Why?
|
| Fibronectins | 1 | 2009 | 726 | 0.270 |
Why?
|
| Liability, Legal | 1 | 2007 | 213 | 0.270 |
Why?
|
| Emergency Service, Hospital | 9 | 2019 | 7659 | 0.260 |
Why?
|
| Fluid Therapy | 2 | 2009 | 593 | 0.260 |
Why?
|
| Health Services | 1 | 2011 | 758 | 0.260 |
Why?
|
| Amylases | 9 | 1999 | 173 | 0.260 |
Why?
|
| Cystadenocarcinoma | 3 | 1996 | 55 | 0.260 |
Why?
|
| Hospitals, University | 2 | 2006 | 571 | 0.250 |
Why?
|
| C-Reactive Protein | 3 | 2014 | 3778 | 0.250 |
Why?
|
| Serologic Tests | 2 | 2023 | 374 | 0.250 |
Why?
|
| Pathology Department, Hospital | 1 | 2004 | 10 | 0.250 |
Why?
|
| Cholesterol | 1 | 2014 | 2917 | 0.250 |
Why?
|
| Pancreatitis, Acute Necrotizing | 6 | 2006 | 172 | 0.250 |
Why?
|
| Donor Selection | 1 | 2006 | 201 | 0.250 |
Why?
|
| Mercury | 2 | 2005 | 285 | 0.250 |
Why?
|
| Outsourced Services | 1 | 2004 | 21 | 0.250 |
Why?
|
| Diagnosis, Differential | 14 | 2019 | 12959 | 0.240 |
Why?
|
| Heart Failure | 9 | 2014 | 10900 | 0.240 |
Why?
|
| Self Care | 1 | 2009 | 786 | 0.240 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2005 | 128 | 0.230 |
Why?
|
| Microbiology | 2 | 2001 | 72 | 0.230 |
Why?
|
| Blood Coagulation Tests | 2 | 2018 | 263 | 0.230 |
Why?
|
| Sodium | 2 | 2008 | 1623 | 0.230 |
Why?
|
| Coronary Artery Disease | 2 | 2014 | 6487 | 0.220 |
Why?
|
| Giant Cell Tumors | 2 | 1995 | 99 | 0.220 |
Why?
|
| Predictive Value of Tests | 14 | 2017 | 15076 | 0.220 |
Why?
|
| Hospitals | 3 | 2022 | 3952 | 0.220 |
Why?
|
| Medical History Taking | 1 | 2006 | 783 | 0.210 |
Why?
|
| Clinical Protocols | 1 | 2008 | 1462 | 0.210 |
Why?
|
| Cyst Fluid | 2 | 1999 | 76 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2023 | 3870 | 0.210 |
Why?
|
| Ubiquinone | 1 | 2003 | 188 | 0.210 |
Why?
|
| Medical Informatics | 1 | 2009 | 745 | 0.210 |
Why?
|
| Immunoglobulin M | 2 | 2023 | 1537 | 0.200 |
Why?
|
| Health Services Misuse | 1 | 2003 | 243 | 0.200 |
Why?
|
| Serum Albumin | 1 | 2005 | 676 | 0.200 |
Why?
|
| Borrelia burgdorferi | 1 | 2023 | 180 | 0.200 |
Why?
|
| Pregnancy Tests | 1 | 2001 | 30 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2023 | 566 | 0.190 |
Why?
|
| Necrosis | 12 | 2014 | 1643 | 0.190 |
Why?
|
| Antibodies, Bacterial | 2 | 2023 | 1470 | 0.190 |
Why?
|
| Middle Aged | 51 | 2017 | 213383 | 0.190 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 3396 | 0.190 |
Why?
|
| Graft Rejection | 1 | 2014 | 4397 | 0.190 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3110 | 0.180 |
Why?
|
| Blood Specimen Collection | 3 | 2003 | 246 | 0.180 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2020 | 37 | 0.180 |
Why?
|
| Anaplasmosis | 1 | 2020 | 36 | 0.180 |
Why?
|
| Total Quality Management | 1 | 2001 | 274 | 0.180 |
Why?
|
| Blood Transfusion | 1 | 2006 | 1301 | 0.180 |
Why?
|
| Database Management Systems | 2 | 2012 | 270 | 0.170 |
Why?
|
| Algorithms | 6 | 2023 | 13881 | 0.170 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5034 | 0.160 |
Why?
|
| Substance Abuse Detection | 1 | 2001 | 283 | 0.160 |
Why?
|
| Internship and Residency | 1 | 2018 | 5788 | 0.160 |
Why?
|
| Boston | 10 | 2016 | 9313 | 0.160 |
Why?
|
| Hydrochloric Acid | 1 | 1997 | 76 | 0.150 |
Why?
|
| Cost Savings | 2 | 2014 | 926 | 0.150 |
Why?
|
| Male | 78 | 2017 | 350118 | 0.150 |
Why?
|
| Venous Thromboembolism | 1 | 2009 | 1671 | 0.140 |
Why?
|
| Myocardial Ischemia | 2 | 2005 | 2148 | 0.140 |
Why?
|
| Female | 56 | 2017 | 380194 | 0.140 |
Why?
|
| Cooperative Behavior | 1 | 2004 | 1504 | 0.140 |
Why?
|
| Drug Prescriptions | 1 | 2006 | 1637 | 0.140 |
Why?
|
| Ascitic Fluid | 2 | 1997 | 192 | 0.140 |
Why?
|
| Prospective Studies | 16 | 2020 | 53288 | 0.140 |
Why?
|
| Acute Disease | 22 | 2007 | 7149 | 0.140 |
Why?
|
| Biopsy, Needle | 4 | 2003 | 1641 | 0.140 |
Why?
|
| Monitoring, Physiologic | 2 | 1995 | 1738 | 0.140 |
Why?
|
| Inservice Training | 2 | 2016 | 392 | 0.140 |
Why?
|
| Unnecessary Procedures | 2 | 2017 | 432 | 0.140 |
Why?
|
| Monitoring, Ambulatory | 2 | 2009 | 355 | 0.140 |
Why?
|
| Australia | 1 | 2019 | 1170 | 0.130 |
Why?
|
| Kidney Function Tests | 2 | 2011 | 684 | 0.130 |
Why?
|
| Blood Coagulation Factors | 1 | 2018 | 355 | 0.130 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 964 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2005 | 1344 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 2 | 2015 | 2170 | 0.130 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 1995 | 98 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 4462 | 0.130 |
Why?
|
| Time Factors | 16 | 2018 | 40075 | 0.130 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 4560 | 0.130 |
Why?
|
| Medical Order Entry Systems | 2 | 2017 | 545 | 0.130 |
Why?
|
| Adult | 34 | 2020 | 214055 | 0.120 |
Why?
|
| False Positive Reactions | 2 | 2008 | 981 | 0.120 |
Why?
|
| Body Fluids | 5 | 2004 | 319 | 0.120 |
Why?
|
| Physician Executives | 1 | 2014 | 128 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2013 | 69 | 0.110 |
Why?
|
| Work | 1 | 2014 | 191 | 0.110 |
Why?
|
| Proprotein Convertases | 1 | 2014 | 95 | 0.110 |
Why?
|
| Immunoassay | 2 | 2009 | 752 | 0.110 |
Why?
|
| Aged, 80 and over | 18 | 2017 | 57776 | 0.110 |
Why?
|
| United States | 11 | 2019 | 69872 | 0.110 |
Why?
|
| Coronary Disease | 6 | 2005 | 6077 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2006 | 8301 | 0.110 |
Why?
|
| RNA | 1 | 2022 | 2749 | 0.100 |
Why?
|
| Meglumine | 1 | 1992 | 149 | 0.100 |
Why?
|
| Capillaries | 4 | 2012 | 773 | 0.100 |
Why?
|
| Aged | 35 | 2017 | 163280 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2017 | 719 | 0.100 |
Why?
|
| Quality Improvement | 2 | 2020 | 3749 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2005 | 3297 | 0.100 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2013 | 224 | 0.100 |
Why?
|
| Prothrombin Time | 1 | 2012 | 119 | 0.100 |
Why?
|
| Diatomaceous Earth | 1 | 2011 | 5 | 0.100 |
Why?
|
| Kaolin | 1 | 2011 | 15 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2013 | 2557 | 0.100 |
Why?
|
| Cysts | 3 | 1996 | 678 | 0.100 |
Why?
|
| Medical Errors | 2 | 2012 | 1297 | 0.100 |
Why?
|
| Efficiency | 1 | 2014 | 462 | 0.100 |
Why?
|
| DNA, Neoplasm | 2 | 1997 | 1758 | 0.100 |
Why?
|
| Confusion | 1 | 2013 | 275 | 0.100 |
Why?
|
| Angina, Unstable | 3 | 2005 | 926 | 0.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 15165 | 0.100 |
Why?
|
| Hospitals, Teaching | 2 | 1994 | 1179 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2017 | 19905 | 0.100 |
Why?
|
| Blood Platelets | 2 | 2022 | 2508 | 0.100 |
Why?
|
| Coronary Artery Bypass | 4 | 2005 | 2289 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2017 | 1486 | 0.090 |
Why?
|
| Decision Trees | 1 | 2012 | 506 | 0.090 |
Why?
|
| Pancreatitis, Alcoholic | 2 | 2002 | 30 | 0.090 |
Why?
|
| Vomiting | 1 | 2013 | 636 | 0.090 |
Why?
|
| Hospitals, General | 1 | 2014 | 749 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2017 | 8324 | 0.090 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2011 | 194 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4397 | 0.090 |
Why?
|
| Rats | 28 | 2006 | 24260 | 0.090 |
Why?
|
| Heart Diseases | 5 | 2009 | 2788 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 865 | 0.090 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2009 | 114 | 0.080 |
Why?
|
| Viscosity | 3 | 1995 | 328 | 0.080 |
Why?
|
| Guidelines as Topic | 2 | 2009 | 1405 | 0.080 |
Why?
|
| Esophageal Fistula | 1 | 1989 | 64 | 0.080 |
Why?
|
| Glycodeoxycholic Acid | 8 | 1999 | 23 | 0.080 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2009 | 99 | 0.080 |
Why?
|
| Peptides | 4 | 1996 | 4409 | 0.080 |
Why?
|
| HIV Infections | 2 | 2012 | 16718 | 0.080 |
Why?
|
| Oligopeptides | 8 | 2001 | 1189 | 0.080 |
Why?
|
| von Willebrand Factor | 3 | 2002 | 669 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1989 | 152 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2009 | 179 | 0.080 |
Why?
|
| Serine Endopeptidases | 1 | 2014 | 1072 | 0.080 |
Why?
|
| Cystadenoma, Mucinous | 2 | 1998 | 59 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 1438 | 0.080 |
Why?
|
| Massachusetts | 6 | 2004 | 8663 | 0.080 |
Why?
|
| Electronic Health Records | 2 | 2018 | 4468 | 0.080 |
Why?
|
| Hospital Costs | 2 | 2004 | 985 | 0.080 |
Why?
|
| Primary Health Care | 2 | 2020 | 4558 | 0.080 |
Why?
|
| Fistula | 1 | 1989 | 220 | 0.080 |
Why?
|
| Hospitals, Urban | 1 | 2009 | 499 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 2 | 2002 | 460 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5078 | 0.070 |
Why?
|
| Blood Urea Nitrogen | 1 | 2007 | 191 | 0.070 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2007 | 61 | 0.070 |
Why?
|
| Electrocardiography | 3 | 2012 | 6442 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2013 | 1063 | 0.070 |
Why?
|
| Bone and Bones | 1 | 1997 | 2575 | 0.070 |
Why?
|
| Radioimmunoassay | 1 | 2007 | 919 | 0.070 |
Why?
|
| Artificial Intelligence | 2 | 2017 | 2214 | 0.070 |
Why?
|
| Leukocyte Count | 3 | 2005 | 1588 | 0.070 |
Why?
|
| Time | 1 | 2008 | 542 | 0.070 |
Why?
|
| Protein C | 1 | 2006 | 138 | 0.070 |
Why?
|
| Teratogens | 1 | 2006 | 112 | 0.070 |
Why?
|
| Proteins | 2 | 1998 | 6103 | 0.070 |
Why?
|
| Blood Cell Count | 3 | 2020 | 403 | 0.070 |
Why?
|
| Ethanol | 4 | 2002 | 1342 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2009 | 7279 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2453 | 0.070 |
Why?
|
| Pancreatic Diseases | 3 | 1997 | 350 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2019 | 3209 | 0.070 |
Why?
|
| Carcinoma, Papillary | 2 | 2003 | 783 | 0.070 |
Why?
|
| Statistics, Nonparametric | 3 | 2007 | 2886 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3605 | 0.060 |
Why?
|
| Physical Exertion | 1 | 2008 | 695 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2020 | 77449 | 0.060 |
Why?
|
| Pulmonary Embolism | 2 | 2009 | 2376 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1127 | 0.060 |
Why?
|
| Prolactin | 1 | 2007 | 669 | 0.060 |
Why?
|
| Serum | 1 | 2006 | 214 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2023 | 23338 | 0.060 |
Why?
|
| Northwestern United States | 1 | 2004 | 20 | 0.060 |
Why?
|
| Angina Pectoris | 2 | 2005 | 977 | 0.060 |
Why?
|
| Bone Density | 1 | 1997 | 3468 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2008 | 1130 | 0.060 |
Why?
|
| Potassium | 1 | 2008 | 1336 | 0.060 |
Why?
|
| Professional Staff Committees | 1 | 2003 | 38 | 0.060 |
Why?
|
| Neoplasms | 2 | 2022 | 21683 | 0.060 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2005 | 113 | 0.060 |
Why?
|
| Pesticide Residues | 1 | 2005 | 95 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 683 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2004 | 160 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 390 | 0.060 |
Why?
|
| Decision Making, Organizational | 1 | 2004 | 139 | 0.060 |
Why?
|
| Stroke | 1 | 2006 | 9981 | 0.060 |
Why?
|
| Coenzymes | 1 | 2003 | 91 | 0.060 |
Why?
|
| Urban Population | 2 | 2009 | 2021 | 0.060 |
Why?
|
| Information Systems | 1 | 2005 | 410 | 0.060 |
Why?
|
| Dehydration | 1 | 2005 | 234 | 0.060 |
Why?
|
| Reference Standards | 2 | 2022 | 1025 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2007 | 1154 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 1989 | 742 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 638 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2018 | 7729 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4328 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2004 | 462 | 0.060 |
Why?
|
| Hematology | 1 | 2006 | 221 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2004 | 15295 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1990 | 1381 | 0.060 |
Why?
|
| Liver Function Tests | 1 | 2004 | 528 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 1715 | 0.050 |
Why?
|
| Incidence | 2 | 2019 | 20947 | 0.050 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2005 | 245 | 0.050 |
Why?
|
| Brain Edema | 1 | 2007 | 617 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5751 | 0.050 |
Why?
|
| Research Design | 1 | 2018 | 5987 | 0.050 |
Why?
|
| Triage | 1 | 2009 | 976 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 1972 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2006 | 733 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5317 | 0.050 |
Why?
|
| Cholesterol Esters | 2 | 2002 | 73 | 0.050 |
Why?
|
| Carcinoma | 2 | 1990 | 2375 | 0.050 |
Why?
|
| Thrombelastography | 1 | 2003 | 164 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2013 | 5985 | 0.050 |
Why?
|
| Lipids | 1 | 2013 | 3305 | 0.050 |
Why?
|
| Patient Admission | 1 | 2009 | 1380 | 0.050 |
Why?
|
| Complement Inactivator Proteins | 1 | 2001 | 79 | 0.050 |
Why?
|
| Hematologic Tests | 2 | 2002 | 240 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 40561 | 0.050 |
Why?
|
| Adenoma | 1 | 1992 | 2174 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2003 | 286 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2006 | 581 | 0.050 |
Why?
|
| Calcium | 3 | 2008 | 5756 | 0.050 |
Why?
|
| Myocardial Revascularization | 1 | 2005 | 841 | 0.050 |
Why?
|
| Colonoscopy | 1 | 2008 | 1367 | 0.050 |
Why?
|
| Guanidines | 1 | 2001 | 193 | 0.050 |
Why?
|
| Fishes | 1 | 2003 | 569 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2012 | 4577 | 0.050 |
Why?
|
| Seafood | 1 | 2003 | 384 | 0.050 |
Why?
|
| Risk Factors | 5 | 2017 | 72290 | 0.050 |
Why?
|
| Pancreatic Ducts | 4 | 1994 | 328 | 0.050 |
Why?
|
| Prognosis | 8 | 2016 | 29063 | 0.050 |
Why?
|
| American Heart Association | 1 | 2005 | 1056 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2009 | 1563 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2009 | 1239 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2003 | 1066 | 0.040 |
Why?
|
| Adenocarcinoma, Mucinous | 3 | 2003 | 506 | 0.040 |
Why?
|
| Medical Records | 1 | 2005 | 1413 | 0.040 |
Why?
|
| Commerce | 1 | 2005 | 592 | 0.040 |
Why?
|
| Pregnancy | 3 | 2009 | 29144 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2001 | 841 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2208 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1826 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 434 | 0.040 |
Why?
|
| Physical Examination | 1 | 2005 | 1237 | 0.040 |
Why?
|
| Observer Variation | 1 | 2005 | 2593 | 0.040 |
Why?
|
| Trypsin | 1 | 1999 | 511 | 0.040 |
Why?
|
| Hemostasis | 1 | 2001 | 458 | 0.040 |
Why?
|
| ROC Curve | 3 | 2009 | 3527 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1998 | 135 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 1998 | 2132 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5221 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2002 | 894 | 0.040 |
Why?
|
| Animals | 30 | 2020 | 168757 | 0.040 |
Why?
|
| Polycythemia | 1 | 1999 | 126 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 1998 | 121 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 19229 | 0.040 |
Why?
|
| Workload | 1 | 2004 | 850 | 0.040 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 214 | 0.040 |
Why?
|
| Survival Analysis | 7 | 2004 | 10252 | 0.040 |
Why?
|
| Tissue Embedding | 1 | 1997 | 43 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2866 | 0.040 |
Why?
|
| Palmitic Acids | 1 | 1997 | 54 | 0.040 |
Why?
|
| Diaphyses | 1 | 1997 | 65 | 0.040 |
Why?
|
| Kidney | 1 | 2013 | 7186 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2013 | 20129 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2012 | 5102 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 1171 | 0.040 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2000 | 641 | 0.040 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 12245 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2001 | 791 | 0.040 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1998 | 271 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3200 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 1990 | 4665 | 0.040 |
Why?
|
| Adenoma, Islet Cell | 2 | 1994 | 82 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2006 | 1154 | 0.040 |
Why?
|
| Tissue Polypeptide Antigen | 1 | 1996 | 4 | 0.040 |
Why?
|
| Leucine | 1 | 1998 | 561 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2003 | 1236 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2001 | 1107 | 0.030 |
Why?
|
| Imipenem | 1 | 1996 | 38 | 0.030 |
Why?
|
| Specialization | 1 | 2001 | 777 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2282 | 0.030 |
Why?
|
| Emergencies | 1 | 2002 | 1170 | 0.030 |
Why?
|
| Tyrosine | 1 | 2000 | 1461 | 0.030 |
Why?
|
| Blood | 1 | 1998 | 598 | 0.030 |
Why?
|
| Image Cytometry | 1 | 1996 | 54 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1998 | 708 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2005 | 1207 | 0.030 |
Why?
|
| Ploidies | 1 | 1996 | 281 | 0.030 |
Why?
|
| Edema | 2 | 1997 | 789 | 0.030 |
Why?
|
| Peroxidase | 3 | 2006 | 611 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 1155 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1681 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1177 | 0.030 |
Why?
|
| Pentoxifylline | 1 | 1994 | 55 | 0.030 |
Why?
|
| Exudates and Transudates | 1 | 1995 | 172 | 0.030 |
Why?
|
| Genes, ras | 1 | 1997 | 690 | 0.030 |
Why?
|
| Beer | 1 | 1994 | 127 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2018 | 772 | 0.030 |
Why?
|
| Acyltransferases | 1 | 1996 | 294 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2838 | 0.030 |
Why?
|
| Leukocytes | 3 | 1999 | 2043 | 0.030 |
Why?
|
| Organizational Policy | 1 | 2016 | 429 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1996 | 315 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 3068 | 0.030 |
Why?
|
| Pancreaticoduodenectomy | 2 | 1997 | 503 | 0.030 |
Why?
|
| Enzyme Activation | 5 | 1999 | 3701 | 0.030 |
Why?
|
| Heparin | 1 | 2000 | 1637 | 0.030 |
Why?
|
| Myosins | 1 | 1995 | 409 | 0.030 |
Why?
|
| Vietnam | 1 | 2014 | 408 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2013 | 41006 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2014 | 265 | 0.030 |
Why?
|
| Edetic Acid | 2 | 2003 | 276 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2003 | 2494 | 0.030 |
Why?
|
| Buffers | 1 | 1992 | 147 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13102 | 0.030 |
Why?
|
| Disease Models, Animal | 6 | 2006 | 18029 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 1995 | 409 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2003 | 1634 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1997 | 1101 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 39050 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 5319 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 1992 | 210 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1992 | 313 | 0.030 |
Why?
|
| Survival Rate | 6 | 2007 | 12788 | 0.030 |
Why?
|
| Temperature | 2 | 2003 | 2206 | 0.030 |
Why?
|
| Aneuploidy | 1 | 1996 | 530 | 0.030 |
Why?
|
| Employee Performance Appraisal | 1 | 1992 | 87 | 0.030 |
Why?
|
| Propanolamines | 1 | 1992 | 167 | 0.030 |
Why?
|
| Young Adult | 3 | 2014 | 56430 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 1623 | 0.030 |
Why?
|
| Anticoagulants | 3 | 2003 | 4599 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2012 | 57 | 0.030 |
Why?
|
| Forecasting | 1 | 2001 | 2951 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 1992 | 379 | 0.030 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 1996 | 450 | 0.030 |
Why?
|
| Imidazoles | 1 | 1998 | 1206 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 4258 | 0.030 |
Why?
|
| Tibia | 1 | 1997 | 1077 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1999 | 2617 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2002 | 1536 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 2 | 1998 | 2849 | 0.020 |
Why?
|
| Rats, Inbred Strains | 4 | 1992 | 2186 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2003 | 2245 | 0.020 |
Why?
|
| Dextrans | 1 | 1993 | 595 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1998 | 2015 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2000 | 2158 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 2073 | 0.020 |
Why?
|
| Adolescent | 4 | 2013 | 85781 | 0.020 |
Why?
|
| Mucins | 1 | 1993 | 564 | 0.020 |
Why?
|
| Giant Cells | 1 | 1990 | 187 | 0.020 |
Why?
|
| Enteropeptidase | 2 | 1999 | 10 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 367 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 3 | 1999 | 9274 | 0.020 |
Why?
|
| Plasmacytoma | 1 | 1990 | 183 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 3022 | 0.020 |
Why?
|
| Hypotension | 1 | 1995 | 884 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 11725 | 0.020 |
Why?
|
| Bacterial Infections | 2 | 1996 | 1401 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1999 | 1886 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2004 | 3537 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 1992 | 346 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 5853 | 0.020 |
Why?
|
| Esophageal Diseases | 1 | 1989 | 166 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3086 | 0.020 |
Why?
|
| Adrenal Gland Diseases | 1 | 1989 | 138 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 1993 | 804 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 1989 | 235 | 0.020 |
Why?
|
| Child | 2 | 2013 | 77709 | 0.020 |
Why?
|
| Epithelium | 1 | 1992 | 1679 | 0.020 |
Why?
|
| Veins | 1 | 2012 | 770 | 0.020 |
Why?
|
| Chi-Square Distribution | 3 | 2003 | 3508 | 0.020 |
Why?
|
| Rats, Wistar | 3 | 1998 | 1901 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2003 | 4838 | 0.020 |
Why?
|
| Osteoclasts | 1 | 1990 | 729 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 2187 | 0.020 |
Why?
|
| Ascites | 3 | 1994 | 344 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2002 | 2645 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1990 | 1100 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1907 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2003 | 504 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2001 | 1420 | 0.020 |
Why?
|
| Thrombosis | 1 | 1999 | 2968 | 0.020 |
Why?
|
| Alcoholism | 1 | 1996 | 1906 | 0.020 |
Why?
|
| Random Allocation | 3 | 1995 | 2429 | 0.020 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1993 | 949 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.020 |
Why?
|
| Kinetics | 1 | 1992 | 6473 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1995 | 2942 | 0.020 |
Why?
|
| Diastole | 1 | 2006 | 791 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 1996 | 11031 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1995 | 11366 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 565 | 0.010 |
Why?
|
| Reticulocyte Count | 1 | 2003 | 37 | 0.010 |
Why?
|
| Ampulla of Vater | 1 | 2003 | 141 | 0.010 |
Why?
|
| Platelet Count | 1 | 2005 | 781 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 1992 | 1206 | 0.010 |
Why?
|
| Regression Analysis | 2 | 2004 | 6459 | 0.010 |
Why?
|
| Glass | 1 | 2003 | 114 | 0.010 |
Why?
|
| Sex Factors | 2 | 2014 | 10397 | 0.010 |
Why?
|
| Risk | 2 | 2007 | 9687 | 0.010 |
Why?
|
| Plastics | 1 | 2003 | 123 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 3703 | 0.010 |
Why?
|
| Delphi Technique | 1 | 2005 | 778 | 0.010 |
Why?
|
| Gabexate | 1 | 2001 | 12 | 0.010 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2002 | 119 | 0.010 |
Why?
|
| Evans Blue | 1 | 2001 | 45 | 0.010 |
Why?
|
| Benzamidines | 1 | 2001 | 25 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1993 | 3036 | 0.010 |
Why?
|
| Inflammation | 2 | 2017 | 10638 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2001 | 193 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1992 | 8436 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9438 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6196 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2001 | 25625 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2010 | 2250 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 2001 | 322 | 0.010 |
Why?
|
| Contrast Media | 1 | 1994 | 5300 | 0.010 |
Why?
|
| Peritoneum | 1 | 2001 | 228 | 0.010 |
Why?
|
| Microscopy | 1 | 2005 | 903 | 0.010 |
Why?
|
| Equipment and Supplies | 1 | 2003 | 281 | 0.010 |
Why?
|
| Endosonography | 1 | 2004 | 610 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2001 | 179 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2006 | 8554 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2002 | 3798 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1999 | 163 | 0.010 |
Why?
|
| Blood Viscosity | 1 | 1999 | 124 | 0.010 |
Why?
|
| Detergents | 1 | 1999 | 230 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1990 | 1596 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1842 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 821 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1998 | 275 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2006 | 15540 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1998 | 255 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2373 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2001 | 673 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2001 | 798 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2006 | 63114 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 7181 | 0.010 |
Why?
|
| Carcinogens | 1 | 1999 | 466 | 0.010 |
Why?
|
| Lung | 3 | 2001 | 9856 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2005 | 1873 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18370 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2012 | 4687 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 2187 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6622 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1999 | 772 | 0.010 |
Why?
|
| Isoamylase | 1 | 1995 | 11 | 0.010 |
Why?
|
| Calcium Chloride | 1 | 1995 | 77 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 916 | 0.010 |
Why?
|
| Indium Radioisotopes | 1 | 1995 | 118 | 0.010 |
Why?
|
| Ethionine | 1 | 1994 | 11 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1996 | 315 | 0.010 |
Why?
|
| Arginine | 1 | 1998 | 944 | 0.010 |
Why?
|
| Choline Deficiency | 1 | 1994 | 28 | 0.010 |
Why?
|
| Blood Volume | 1 | 1995 | 565 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1997 | 640 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 977 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1994 | 331 | 0.010 |
Why?
|
| Metaplasia | 1 | 1995 | 313 | 0.010 |
Why?
|
| Ligation | 1 | 1994 | 453 | 0.010 |
Why?
|
| Enterococcus | 1 | 1994 | 157 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1993 | 378 | 0.010 |
Why?
|
| DNA Primers | 1 | 1997 | 2892 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 25043 | 0.010 |
Why?
|
| Phenotype | 1 | 1990 | 16365 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 5391 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 1993 | 119 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1993 | 110 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1992 | 55 | 0.010 |
Why?
|
| Abscess | 1 | 1996 | 607 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1998 | 2618 | 0.010 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 1994 | 341 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1994 | 625 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2002 | 2149 | 0.010 |
Why?
|
| Duodenum | 1 | 1994 | 483 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1994 | 1107 | 0.010 |
Why?
|
| Permeability | 1 | 1993 | 738 | 0.010 |
Why?
|
| Injections | 1 | 1994 | 840 | 0.010 |
Why?
|
| Perineum | 1 | 1992 | 211 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1995 | 2031 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 1994 | 532 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 6489 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1992 | 382 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 21746 | 0.010 |
Why?
|
| Elastic Tissue | 1 | 1989 | 65 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1994 | 1375 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8949 | 0.010 |
Why?
|
| Microcirculation | 1 | 1993 | 1286 | 0.000 |
Why?
|
| Fluorouracil | 1 | 1993 | 1619 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1996 | 1809 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6171 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1994 | 1782 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 1182 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 2274 | 0.000 |
Why?
|
| Adrenal Glands | 1 | 1989 | 546 | 0.000 |
Why?
|
| Radiotherapy Dosage | 1 | 1993 | 2879 | 0.000 |
Why?
|
| Abdomen | 1 | 1992 | 1118 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1994 | 6365 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1994 | 1400 | 0.000 |
Why?
|
| Linear Models | 1 | 1995 | 5952 | 0.000 |
Why?
|
| Bacteria | 1 | 1996 | 2114 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1990 | 806 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1995 | 3461 | 0.000 |
Why?
|
| Intestines | 1 | 1993 | 1924 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1996 | 3966 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10943 | 0.000 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1989 | 1504 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1990 | 20822 | 0.000 |
Why?
|
| Calcinosis | 1 | 1990 | 1499 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1992 | 4199 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1993 | 8642 | 0.000 |
Why?
|
| Prevalence | 1 | 1997 | 15226 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 13815 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 18111 | 0.000 |
Why?
|
| Diet | 1 | 1994 | 7939 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1992 | 9239 | 0.000 |
Why?
|
| Mice | 1 | 1994 | 81183 | 0.000 |
Why?
|